Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
-2.36%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$46.8B
AUM Growth
-$2.48B
(-5%)
Cap. Flow
-$759M
Cap. Flow
% of AUM
-1.62%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30
Top Buys
| 1 |
Crown Castle
CCI
|
+$116M |
| 2 |
Amgen
AMGN
|
+$103M |
| 3 |
Progressive
PGR
|
+$101M |
| 4 |
AbbVie
ABBV
|
+$78.3M |
| 5 |
MetLife
MET
|
+$66.2M |
Top Sells
| 1 |
Eli Lilly
LLY
|
+$155M |
| 2 |
Johnson & Johnson
JNJ
|
+$139M |
| 3 |
LyondellBasell Industries
LYB
|
+$106M |
| 4 |
Exxon Mobil
XOM
|
+$93.9M |
| 5 |
Apple
AAPL
|
+$77.4M |
Sector Composition
| 1 | Technology | 24.49% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 12.52% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Encompass Health
EHC
$12.6B
| $2.23M | ﹤0.01% |
33,142
-2,520
| -7% | -$169K |
|
802
Cullen/Frost Bankers
CFR
$8.11B
| $2.22M | ﹤0.01% |
24,363
+5,344
| +28% | +$487K |
|
803
Chart Industries
GTLS
$8.95B
| $2.21M | ﹤0.01% |
13,070
| – | – |
|
804
Tenet Healthcare
THC
$16.9B
| $2.2M | ﹤0.01% |
33,433
| – | – |
|
805
Equity Residential
EQR
$25.2B
| $2.19M | ﹤0.01% |
37,348
-9,641
| -21% | -$566K |
|
806
Fortis
FTS
$24.7B
| $2.19M | ﹤0.01% |
57,351
+9,100
| +19% | +$347K |
|
|
SWAV
807
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $2.19M | ﹤0.01% |
10,980
-505
| -4% | -$101K |
|
808
Royal Gold
RGLD
$12.3B
| $2.18M | ﹤0.01% |
20,513
| – | – |
|
809
Jones Lang LaSalle
JLL
$14.6B
| $2.17M | ﹤0.01% |
15,380
+1,515
| +11% | +$214K |
|
810
Universal Display
OLED
$6.52B
| $2.17M | ﹤0.01% |
13,820
| – | – |
|
811
Woodward
WWD
$14.3B
| $2.17M | ﹤0.01% |
17,429
| – | – |
|
812
Murphy Oil
MUR
$3.72B
| $2.16M | ﹤0.01% |
47,525
| – | – |
|
813
Primerica
PRI
$8.74B
| $2.15M | ﹤0.01% |
11,096
| – | – |
|
814
Nutrien
NTR
$27.9B
| $2.15M | ﹤0.01% |
34,639
+100
| +0.3% | +$6.21K |
|
815
Rambus
RMBS
$8.3B
| $2.15M | ﹤0.01% |
38,502
-16,105
| -29% | -$898K |
|
816
Ciena
CIEN
$18.4B
| $2.14M | ﹤0.01% |
45,274
| – | – |
|
817
Antero Resources
AR
$10.1B
| $2.13M | ﹤0.01% |
83,980
-8,745
| -9% | -$222K |
|
818
Polaris
PII
$3.29B
| $2.12M | ﹤0.01% |
20,391
+2,185
| +12% | +$228K |
|
819
Silicon Laboratories
SLAB
$4.34B
| $2.12M | ﹤0.01% |
18,275
+5,561
| +44% | +$644K |
|
820
Neumora Therapeutics
NMRA
$264M
| $2.12M | ﹤0.01% |
+150,000
| New | +$2.12M |
|
821
Medpace
MEDP
$13.4B
| $2.12M | ﹤0.01% |
8,735
+265
| +3% | +$64.2K |
|
822
Gentex
GNTX
$6.15B
| $2.11M | ﹤0.01% |
64,911
-17,215
| -21% | -$560K |
|
823
American Financial Group
AFG
$11.4B
| $2.11M | ﹤0.01% |
18,871
| – | – |
|
824
Kite Realty
KRG
$4.97B
| $2.1M | ﹤0.01% |
98,069
+16,690
| +21% | +$358K |
|
825
Ionis Pharmaceuticals
IONS
$10.2B
| $2.1M | ﹤0.01% |
46,310
| – | – |
|